Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Appoints New Director Karen S. Lynch
Summary
On February 19, 2025, Thermo Fisher Scientific Inc. expanded its Board of Directors to twelve members by electing Karen S. Lynch as a new director, effective immediately. Ms. Lynch, a seasoned health care executive with extensive experience, will serve until the 2025 annual meeting and is expected to join the Audit Committee post-reelection. Her compensation and indemnification arrangements align with those of other non-employee directors.
Profitelligence Alerts
Get alerts for TMO
Be first to know when Thermo Fisher Scientific Inc. files with the SEC.
Filing Categories
Advertisement
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Official SEC Documents
Advertisement